How Do You Value a Pre-Revenue Startup?
Berkus, Scorecard and the VC Method

Short answer

Investors value pre-revenue startups with qualitative frameworks: the Berkus Method assigns up to $500K across five risk areas (capping around $2.5M), the Scorecard Method adjusts the regional median valuation by weighted factors — team counts ~30%, market ~25% — and the VC Method works backwards from a target exit value and expected return.

You have a prototype, two co-founders and zero revenue — and an angel just asked what valuation you're raising at. The honest answer is that valuing a pre-revenue startup isn't a calculation, it's a structured negotiation, and investors bring three named frameworks to it. Learn how each one assigns a number to your risk and you stop being the only person in the room without a method.

How do you value a startup with no revenue?

With no financials to discount, investors price the risks you've already removed. Every pre-revenue method is a different way of asking the same question: how much closer is this team to a fundable, revenue-producing business than a blank sheet of paper? Three frameworks dominate.

1. The Berkus Method: five risks, $500K each

Angel investor Dave Berkus's method assigns a dollar value — commonly up to $500K — to each of five risk-reduction drivers, capping the pre-revenue valuation around $2.5M:

Its strength is discipline: it forces both sides to say which risks are actually retired. Its weakness is the cap — in hot sectors or expensive regions, $2.5M is below market, which is why Berkus himself framed the numbers as adjustable to local conditions (Finro's 2025 pre-revenue valuation guide treats the bands as a starting grid, not gospel).

2. The Scorecard Method: the regional median, adjusted

The Scorecard (or Bill Payne) Method is the angel community's workhorse. It starts from the median pre-money valuation for comparable pre-revenue deals in your region, then adjusts it up or down across seven weighted factors. Per Eqvista's breakdown of the method, the classic weights are:

1. Strength of the team — up to 30% (the heaviest factor)
2. Size of the opportunity — up to 25%
3. Product / technology — up to 15%
4. Competitive environment — up to 10%
5. Marketing / sales channels — up to 10%
6. Need for additional financing — up to 5%
7. Other factors — up to 5%

Score each factor relative to the average funded startup (1.0 = average), multiply by the weight, sum the results, and multiply that composite by the regional median. Note what the weights say: team and market together are worth up to 55% of the entire valuation. At pre-revenue, investors are pricing the people and the prize, not the product.

The anchor number is doing most of the work, so get it right. In the US, Carta's pre-seed data puts typical SAFE caps in the mid-single-digit millions to low teens depending on sector and geography. In Europe, PitchBook's Q3 2025 report puts the median pre-seed/seed pre-money at about EUR 5.0M — materially below comparable US figures, a gap we unpack in why European startups are valued below US peers.

3. The VC Method: working backwards from the exit

The VC Method ignores your present and prices your ending:

Post-money valuation = expected exit value ÷ target return multiple

An investor who believes your company could exit at $60M and wants a 20x return will pay up to a $3M post-money today (then adjust for expected dilution from future rounds). It sounds crude, but it reveals exactly how investors think: they're not buying your prototype, they're buying a probability-weighted slice of an exit. If your market can't plausibly support an exit large enough to return their fund, no scorecard polish will save the deal.

Once a number is agreed, remember it will be quoted as pre- or post-money — and the difference changes your dilution. If that distinction isn't second nature yet, read pre-money vs post-money valuation before your first term sheet.

A worked example: one startup, three numbers

Say you're a two-person B2B software team in Berlin: working prototype, one pilot LOI, first-time founders, big market.

• Berkus: idea $400K + prototype $400K + team $300K + relationships (pilot LOI) $250K + rollout $0 = ~EUR 1.35M.
• Scorecard: regional median EUR 5.0M (PitchBook Q3 2025) × composite of 0.9 (average team at 30%, strong market at 25%, solid product, crowded competition) = ~EUR 4.5M.
• VC Method: plausible EUR 50M exit ÷ 20x target = EUR 2.5M post-money; after expected future dilution of ~40%, roughly EUR 1.5M effective today.

Three defensible methods, a 3x spread. That spread is the negotiation range. Your job in the pitch is to move the scorecard multipliers — evidence of team strength and market size — because they carry 55% of the weight.

What most founders get wrong

The instinct is to argue for the biggest number. The better move is to argue for the most fundable number. A pre-revenue valuation only "wins" if your next round clears above it comfortably; price today at a level your 18-month milestones can double or triple, and you avoid the flat round that stalls hiring and spooks new investors. Revenue-stage pricing has its own logic — multiples of ARR driven by growth and retention — which is exactly where you're headed next; see the SaaS valuation multiples in 2026 to understand the bar your seed valuation will be judged against later.

What this means for you

Walk into every pre-revenue negotiation with three prepared numbers: your Berkus build-up, your Scorecard result anchored to a named regional median, and the VC Method implied ceiling for your realistic exit. Present the scorecard logic, not just the conclusion — investors respect founders who price risk the way they do. And treat team and market evidence as your highest-return prep: they move 55% of the number.